UBS Knock-Out TEVA/ DE000UL50A00 /
9/5/2024 8:58:18 AM | Chg.+0.040 | Bid10:05:51 AM | Ask10:05:51 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.950EUR | +4.40% | 0.960 Bid Size: 25,000 |
0.970 Ask Size: 25,000 |
Teva Pharmaceutical ... | 8.6724 USD | 12/31/2078 | Call |
Master data
Issuer: | UBS AG, LONDON BRANCH |
---|---|
WKN: | UL50A0 |
Currency: | EUR |
Underlying: | Teva Pharmaceutical Industries Ltd |
Type: | Knock-out |
Option type: | Call |
Strike price: | 8.6724 USD |
Maturity: | Endless |
Issue date: | 7/13/2023 |
Last trading day: | 12/31/2078 |
Ratio: | 10:1 |
Exercise type: | Bermuda |
Quanto: | No |
Gearing: | 1.76 |
Knock-out: | 8.6724 |
Knock-out violated on: | - |
Distance to knock-out: | 9.1153 |
Distance to knock-out %: | 53.81% |
Distance to strike price: | 9.1153 |
Distance to strike price %: | 53.81% |
Calculated values
Fair value: | - |
---|---|
Implied volatility: | - |
Historic volatility: | - |
Parity: | - |
Time value: | - |
Break-even: | - |
Moneyness: | - |
Premium: | 0.02 |
Premium p.a.: | 0.00 |
Spread abs.: | 0.01 |
Spread %: | 1.04% |
Delta: | - |
Theta: | - |
Omega: | - |
Rho: | - |
Quote data
Open: | 0.950 |
---|---|
High: | 0.950 |
Low: | - |
Market phase: | - |
All quotes in EUR
Performance
1 Week | +3.26% | ||
---|---|---|---|
1 Month | +26.67% | ||
3 Months | +21.79% | ||
YTD | +316.67% | ||
1 Year | +408.02% | ||
3 Years | - | ||
5 Years | - | ||
10 Years | - |
1W High / 1W Low: | 0.950 | 0.910 |
---|---|---|
1M High / 1M Low: | 0.950 | 0.750 |
6M High / 6M Low: | 0.950 | 0.400 |
High (YTD): | 9/3/2024 | 0.950 |
Low (YTD): | 1/2/2024 | 0.250 |
52W High: | 9/3/2024 | 0.950 |
52W Low: | 10/24/2023 | 0.028 |
Avg. price 1W: | 0.934 | |
Avg. volume 1W: | 0.000 | |
Avg. price 1M: | 0.870 | |
Avg. volume 1M: | 0.000 | |
Avg. price 6M: | 0.704 | |
Avg. volume 6M: | 0.000 | |
Avg. price 1Y: | 0.470 | |
Avg. volume 1Y: | 0.000 | |
Volatility 1M: | 50.67% | |
Volatility 6M: | 82.45% | |
Volatility 1Y: | 202.25% | |
Volatility 3Y: | - |